Everyone records what a deal cost. We score what it was worth — the gap between what the Street said at announcement and what history actually did. Free, no login.
2,413 published deal records · $5,493.7B in disclosed deal value · 899 graded with post-close outcomes.
This pharma deals database tracks more than 1,500 pharma and biotech business-development transactions — M&A, licensing deals, collaborations, and asset acquisitions — representing nearly $5.4 trillion in disclosed deal value. Coverage runs from the industry's landmark transactions (curated back to 1895) through comprehensive daily deal intelligence since April 2026, with new deals added every day from primary sources.
Every record captures the deal's terms: parties, structure, disclosed value, deal type, therapeutic areas, and lead assets. What sets this deal data apart is hindsight — roughly 900 deals carry a post-close Outcome Score grading how the transaction actually aged, alongside the sourced sentiment it drew at announcement. The gap between the two is the Hype Gap, and the whole deal history is searchable below by company, year, deal type, or disease area.
Search 1,500+ published deal records — scoring where assessable — or browse the full database →
New deals + their historical-outcome read, Monday mornings.